» Articles » PMID: 20802483

Structural Insights into the Assembly and Activation of IL-1β with Its Receptors

Overview
Journal Nat Immunol
Date 2010 Aug 31
PMID 20802483
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin 1β (IL-1β) is a key orchestrator of inflammation and host defense that exerts its effects through IL-1 receptor type I (IL-1RI) and IL-1 receptor accessory protein (IL-1RAcP). How IL-1RAcP is recruited by IL-1β-IL-1RI to form the signaling-competent complex remains elusive. Here we present the crystal structure of IL-1β bound to IL-1 receptor type II (IL-1RII) and IL-1RAcP. IL-1β-IL-1RII generated a composite binding surface to recruit IL-1RAcP. Biochemical analysis demonstrated that IL-1β-IL-1RI and IL-1β-IL-1RII interacted similarly with IL-1RAcP. It also showed the importance of two loops of IL-1 receptor antagonist (IL-1Ra) in determining its antagonism. Our results provide a structural basis for assembly and activation of the IL-1 receptor and offer a general cytokine-receptor architecture that governs the IL-1 family of cytokines.

Citing Articles

The role of the interleukin family in liver fibrosis.

Zhang Z, Wang J, Li H, Niu Q, Tao Y, Zhao X Front Immunol. 2025; 16:1497095.

PMID: 39995661 PMC: 11847652. DOI: 10.3389/fimmu.2025.1497095.


IL-1 Receptor Dynamics in Immune Cells: Orchestrating Immune Precision and Balance.

Kim D, Lee W Immune Netw. 2024; 24(3):e21.

PMID: 38974214 PMC: 11224669. DOI: 10.4110/in.2024.24.e21.


Inflammatory cytokine profiles in erectile dysfunction: a bidirectional Mendelian randomization.

Liu D, Qin Z, Yi B, Xie H, Liang Y, Zhu L Front Immunol. 2024; 15:1342658.

PMID: 38680495 PMC: 11045927. DOI: 10.3389/fimmu.2024.1342658.


Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling.

Fields J, Gyllenback E, Bogacz M, Obi J, Birkedal G, Sjostrom K Cell Rep. 2024; 43(5):114099.

PMID: 38636519 PMC: 11587196. DOI: 10.1016/j.celrep.2024.114099.


Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β.

Hommel U, Hurth K, Rondeau J, Vulpetti A, Ostermeier D, Boettcher A Nat Commun. 2023; 14(1):5497.

PMID: 37679328 PMC: 10484922. DOI: 10.1038/s41467-023-41190-0.


References
1.
Brunger A . Version 1.2 of the Crystallography and NMR system. Nat Protoc. 2007; 2(11):2728-33. DOI: 10.1038/nprot.2007.406. View

2.
Sims J, Nicklin M, Bazan J, Barton J, Busfield S, Ford J . A new nomenclature for IL-1-family genes. Trends Immunol. 2001; 22(10):536-7. DOI: 10.1016/s1471-4906(01)02040-3. View

3.
Schneider T, Sheldrick G . Substructure solution with SHELXD. Acta Crystallogr D Biol Crystallogr. 2002; 58(Pt 10 Pt 2):1772-9. DOI: 10.1107/s0907444902011678. View

4.
Goldbach-Mansky R . Blocking interleukin-1 in rheumatic diseases. Ann N Y Acad Sci. 2010; 1182:111-23. PMC: 3080043. DOI: 10.1111/j.1749-6632.2009.05159.x. View

5.
Malinowsky D, Lundkvist J, Laye S, Bartfai T . Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett. 1998; 429(3):299-302. DOI: 10.1016/s0014-5793(98)00467-0. View